ROC curves identified that the PANDAR levels were a marker for discriminating the early-stage tumour group from the healthy group, the metastasis group from the non-metastasis group and the chemoresistance group from the chemosensitive group in GC patients. The gene discussed is PANDAR; the disease is neoplasm.